Clinical Trials for Nuvation Bio

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Nuvation Bio

Clinical Trials (5)

NCT07154706
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
PHASE3Recruiting
180 participants
Started: Aug 21, 2025 · Completed: Aug 30, 2033
1 condition1 sponsor3 locations
NCT06564324
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
PHASE3Recruiting
138 participants
Started: Nov 27, 2024 · Completed: Sep 30, 2030
1 condition2 sponsors11 locations
NCT06334432
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
466 participants
Started: Mar 14, 2024 · Completed: Oct 31, 2027
5 conditions1 sponsor8 locations
NCT05303519
Safusidenib Phase 2 Study in IDH1 Mutant Glioma
PHASE2Recruiting
125 participants
Started: Jun 5, 2023 · Completed: Mar 1, 2028
5 conditions2 sponsors31 locations
NCT04919811
Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC
PHASE2Active, not recruiting
217 participants
Started: Sep 1, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor77 locations